Literature DB >> 6416158

Effect of osmotic blood-brain barrier disruption on gentamicin penetration into the cerebrospinal fluid and brains of normal rabbits.

L J Strausbaugh, G S Brinker.   

Abstract

Rapid infusion of hyperosmolar solutions into the internal carotid artery transiently disrupts the blood-brain barrier, permitting entry of substances that are ordinarily excluded from the nervous system. This study compared gentamicin concentrations in the cerebrospinal fluid (CSF) and brain tissue of rabbits receiving intracarotid infusions of 2 molal mannitol with those in three groups of control animals. After catheter placement and intravenous gentamicin administration (20 mg/kg), rabbits received either 2 molal mannitol in the internal carotid artery, 2 molal mannitol intravenously, 0.9% saline in the internal carotid artery, or 0.9% saline intravenously. Mannitol and saline were administered in 8-ml bolus injections over 40 s. After 2 h, serum, CSF, and brain specimens were obtained for antibiotic assay. Gentamicin concentrations in serum were comparable in all groups (mean concentrations ranged from 14.6 to 17.9 micrograms/ml at 60 min and from 5.7 to 7.4 micrograms/ml at 135 min), but gentamicin concentrations in CSF and brains were significantly higher in animals in the group receiving mannitol in the internal carotid artery. In this group the mean gentamicin concentration in CSF, 5.3 micrograms/ml, was twofold greater than those in the other three groups (range, 1.7 to 2.6 micrograms/ml). Similarly, the mean gentamicin concentration in the brains of animals in the group receiving mannitol in the internal carotid artery, 2.3 micrograms/g was significantly higher than those in the other groups (mean of measurable values, 1.4 micrograms/g, in all three control groups). Osmotic disruption of the blood-brain barrier enhanced the penetration of gentamicin into CSF and brain tissue.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416158      PMCID: PMC185128          DOI: 10.1128/AAC.24.2.147

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Blood, brain, and cerebrospinal fluid concentrations of several antibiotics in rabbits with intact and inflamed meninges.

Authors:  T R Beam; J C Allen
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

2.  Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery.

Authors:  E A Neuwelt; K R Maravilla; E P Frenkel; S I Rapaport; S A Hill; P A Barnett
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

3.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

4.  Designing appropriate therapy in the treatment of gram-negative bacillary meningitis.

Authors:  M L Corrado; M E Gombert; C E Cherubin
Journal:  JAMA       Date:  1982-07-02       Impact factor: 56.272

5.  Intraventricular use of aminoglycosides in the treatment of gram-negative bacillary meningitis: conflicting views.

Authors:  M N Swartz
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

6.  Penicillin neurotoxicity.

Authors:  P I Lerner; H Smith; L Weinstein
Journal:  Ann N Y Acad Sci       Date:  1967-09-27       Impact factor: 5.691

7.  Reversible osmotic blood-brain barrier disruption in humans: implications for the chemotherapy of malignant brain tumors.

Authors:  E A Neuwelt; E P Frenkel; J Diehl; L H Vu; S Rapoport; S Hill
Journal:  Neurosurgery       Date:  1980-07       Impact factor: 4.654

8.  Neurotoxicity of intrathecal gentamicin: a case report and experimental study.

Authors:  I Watanabe; G R Hodges; D L Dworzack; J J Kepes; G F Duensing
Journal:  Ann Neurol       Date:  1978-12       Impact factor: 10.422

9.  Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives.

Authors:  R G Dacey; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

Review 10.  Host defense and antimicrobial therapy in adult gram-negative bacillary meningitis.

Authors:  J J Rahal; M S Simberkoff
Journal:  Ann Intern Med       Date:  1982-04       Impact factor: 25.391

View more
  4 in total

1.  The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse.

Authors:  Dan Wang; Valery Belakhov; Jeyakumar Kandasamy; Timor Baasov; Su-Chen Li; Yu-Teh Li; David M Bedwell; Kim M Keeling
Journal:  Mol Genet Metab       Date:  2011-10-19       Impact factor: 4.797

2.  Distribution of gentamicin by immunofluorescence in the guinea pig inner ear.

Authors:  T Hayashida; Y Nomura; M Iwamori; Y Nagai; T Kurata
Journal:  Arch Otorhinolaryngol       Date:  1985

3.  Revisiting intra-arterial drug delivery for treating brain diseases or is it "déjà-vu, all over again"?

Authors:  Shailendra Joshi; Jason A Ellis; Charles W Emala
Journal:  J Neuroanaesth Crit Care       Date:  2014-05

4.  Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation.

Authors:  Dan Wang; Charu Shukla; Xiaoli Liu; Trenton R Schoeb; Lorne A Clarke; David M Bedwell; Kim M Keeling
Journal:  Mol Genet Metab       Date:  2010-01       Impact factor: 4.797

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.